VELIN-PHARMA A/S: Financial statements 2021
CVR: 33026013
Source: annual report 2021, Danish Business Authority
01/06/2020 – 31/05/2021
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 150,155 and a net result of DKK 5,954,072 compared with DKK 3,483,807 the year before. That is a decrease of 46.1% compared with the year before. Equity in the 2021 report amounted to DKK 28,124,288. The solvency ratio was 94.1%.
- Gross Profit
- DKK 150,155
- Profit/Loss
- DKK 5,954,072
- Equity
- DKK 28,124,288
- Total Assets
- DKK 29,882,108
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 150K | 6M | 28.1M | 0 |
| 2020 | - | 279K | 3.5M | 22.2M | - |
| 2019 | - | 139K | -998K | 18.7M | - |
| 2018 | - | 86K | -807K | 19.7M | - |
| 2017 | - | 164K | -147K | 20.5M | - |
Official annual report
Find more companies like VELIN-PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of August 16, 2021, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of VELIN-PHARMA A/S.
As of August 16, 2021, SELSKABET AF 16.08.2021 A/S has stepped down as auditor of VELIN-PHARMA A/S.
About VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.